These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 32472258

  • 21. Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter.
    Wang X, Luo X, Yang L.
    Dig Dis Sci; 2021 Dec; 66(12):4568-4569. PubMed ID: 33634428
    [No Abstract] [Full Text] [Related]

  • 22. Embolization of nonvariceal portosystemic collaterals in transjugular intrahepatic portosystemic shunts.
    Bilbao JI, Arias M, Longo JM, Alejandre PL, Betés MT, Elizalde AM.
    Cardiovasc Intervent Radiol; 1997 Dec; 20(2):149-53. PubMed ID: 9030509
    [Abstract] [Full Text] [Related]

  • 23. [A case of successful treatment of type II hepatorenal syndrome with transjugular intrahepatic portosystemic shunt using carbon dioxide as a contrast medium].
    Tanimura K, Kanazawa H, Yoshimoto H, Koizumi N, Mamiya Y, Osada Y, Kuroda H, Sakamoto T, Kobayashi M, Shimoda T, Arai H, Suzuki H, Abe T.
    Nihon Shokakibyo Gakkai Zasshi; 2001 May; 98(5):559-63. PubMed ID: 11400286
    [No Abstract] [Full Text] [Related]

  • 24. Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Testino G.
    Dig Dis Sci; 2021 Jan; 66(1):325-326. PubMed ID: 32285320
    [No Abstract] [Full Text] [Related]

  • 25. Portal Hypertension.
    Saab S.
    Clin Liver Dis; 2019 Nov; 23(4):xiii-xiv. PubMed ID: 31563223
    [No Abstract] [Full Text] [Related]

  • 26. Hepatic Encephalopathy due to Intrahepatic Portosystemic Shunt via Right Adrenal Vein in a Non-Cirrhotic Patient.
    Hsu JH, Chou MC, Li HM.
    J Emerg Med; 2021 Mar; 60(3):e63-e65. PubMed ID: 33288351
    [No Abstract] [Full Text] [Related]

  • 27. Role of Transjugular Intrahepatic Portosystemic Shunt in the Management of Portal Hypertension: Review and Update of the Literature.
    Hung ML, Lee EW.
    Clin Liver Dis; 2019 Nov; 23(4):737-754. PubMed ID: 31563220
    [Abstract] [Full Text] [Related]

  • 28. Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy.
    Luo J, Li M, Zhang Y, Wang H, Huang M, Li Z, Chen J, Wu C, Qian J, Guan S, Jiang Z.
    Eur Radiol; 2018 Sep; 28(9):3661-3668. PubMed ID: 29600476
    [Abstract] [Full Text] [Related]

  • 29. Type-1 hepatorenal syndrome in patients with alcoholic end stage liver disease listed for liver transplantation: role of transjugular intrahepatic portosystemic stent shunt.
    Testino G, Ferro C.
    Panminerva Med; 2007 Mar; 49(1):43-5. PubMed ID: 17468733
    [No Abstract] [Full Text] [Related]

  • 30. Transjugular Intrahepatic Portosystemic Shunt for a Challenging Pregnancy.
    Kapila N, Dorsey YC, Shah J, King L, Ravindra K, Knechtle S, Patel Y.
    Am J Gastroenterol; 2020 Dec; 115(12):1935. PubMed ID: 32221161
    [No Abstract] [Full Text] [Related]

  • 31. Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy.
    Rössle M, Piotraschke J.
    Dig Dis; 1996 Dec; 14 Suppl 1():12-9. PubMed ID: 8872448
    [Abstract] [Full Text] [Related]

  • 32. Is transjugular intrahepatic portasystemic shunt a panacea for the complications of portal hypertension?
    Boyer TD.
    Hepatology; 1998 Aug; 28(2):590-2. PubMed ID: 9696029
    [No Abstract] [Full Text] [Related]

  • 33. Focal hepatic encephalopathy with status epilepticus: incomplete recovery after hepatic transplantation.
    Annoni JM, Giostra E, Goumaz M, Slosman D, Hadengue A, Mentha G.
    Dig Dis Sci; 1997 Apr; 42(4):792-5. PubMed ID: 9125651
    [No Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of transjugular intrahepatic portosystemic shunt in the treatment of nongastric extraesophageal variceal bleeding.
    Obideen MK, Wehbi M, Ghazale A, Martinez E, Cai Q.
    J Clin Gastroenterol; 2004 Apr; 38(4):373-6. PubMed ID: 15087699
    [Abstract] [Full Text] [Related]

  • 35. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
    Lin ZP, Chen SL, Wang JY, Liu F, Tan Q, Peng QF, Zhao JB.
    Zhonghua Gan Zang Bing Za Zhi; 2020 Aug 20; 28(8):672-678. PubMed ID: 32911906
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.
    Siramolpiwat S.
    World J Gastroenterol; 2014 Dec 07; 20(45):16996-7010. PubMed ID: 25493012
    [Abstract] [Full Text] [Related]

  • 39. [Portosystemic shunts versus endoscopic therapy for esophageal varices after the first bleeding: does the Cochrane analysis give a complete answer?].
    Grønbaek H, Thomsen KL, Ott P, Vilstrup H.
    Ugeskr Laeger; 2007 Aug 20; 169(34):2761-3. PubMed ID: 17878011
    [No Abstract] [Full Text] [Related]

  • 40. [Research advances in diagnosis and treatment of post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy].
    Yang JF, Zhang BQ.
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul 20; 24(7):545-548. PubMed ID: 27784438
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.